Six RNAi-Related Patent Applications Published by the US Patent Office | GenomeWeb

Title: Covalent Modification of RNA for In Vitro and In Vivo Delivery. Number: 20040167090. Filed: Feb. 19, 2004. Lead Inventor: Sean Monahan, Mirus.

According to the patent application’s abstract, the invention comprises “post-synthetic modification of RNA for the delivery of the RNA to a mammalian cell. The modifications enhance [resistance] of the RNA to nuclease digestion, and [enhance] delivery of the RNA to the cell whether the RNA is delivered alone or in combination with a transfection agent,” it states.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.